SHANGHAI--(Business Wire)--The 6th China Human&Veterinary Vaccine Industry Summit 2014 will be held on July 4th-5th in Changchun, China.
Since 2009, CBI Pharma has continuously held China Vaccine Industry Summit for five years. Based on topics like policies, marketing changes, techniques and collaboration, CBI provides a platform for leaders from Governments, Manufactures, Institutions, Equipment providers, Pes & VCs and other related enterprises.
Human Vaccine:
In the aspect of human vaccine, promoted by China’s National Immunization Scheme over years, the rate of group-one vaccines under the scheme rises, which effectively prevent the newborns and children from infection of epidemic diseases. Meanwhile, the variety of vaccines increases and leads to market expansion in short time. As related data show, China's vaccine market has sustained a 15% annual growth. However, the market expansion brings more challenges for Chinese vaccine production enterprises. The emergence of new epidemic diseases, such as H7N9, questioned vaccine enterprises’ emergency R&D ability. Safety accidents of vaccine occur from time to time, which asks the industry to put more effective control on manufacturing, QC, storage, transportation, etc. And the homogenized competition leads enterprises and research institutes to improve technology to ehance the immune effect.
Topics and speakers include:
Keynote Speech: Analysis of Epidemic Tendency in China and over the World and National Immunization Control Strategy
Speaker: National Immunization Program Chinese Center for Disease Control and Prevention
Keynote Speech: Current Situation of China’s Vaccine Industry and Environment for Innovation
Speaker: R&D Department, China National Biotec Group
Keynote Speech: Changes of New Pharmacopoeia in Vaccine
Speaker: Division of Enteric Bacterial Vaccines, NIFDC
Keynote Speech: Influenza Vaccine Production Process Management
Speaker: Head of China Industrial Operations, Sanofi Pasteur
Keynote Speech: Development of Vaccine Formulation
Speaker: Shanghai Zerun Biotech Co.,Ltd
Apart from above topics, we will also focus on Construction and Application of New Vaccine Vectors, Innovative Vaccine Technology Platform, Conjugate Vaccines, Therapeutic Vaccine, etc. Also, as the development of GSK and MERCK’s HPV vaccines in China gains more attention, a panel discussion on collaboration among domestic and multinational enterprises and related government departments will be arranged.
Veterinary Vaccine:
With the human vaccine market expanding, the veterinary vaccine industry also faces great opportunities and challenges. At present, there are over 100 animal vaccine manufacturers in China, with more than 300 production lines. However, most of the enterprises are small in scale, with unqualified vaccine production inspection and poor product structures. The market is dominated by a minority of enterprises.
On one hand, China’s Ministry of Agriculture and Ministry of Finance made the 2013 National Compulsory Immunization Program for Animal Diseases, which requires compulsory immunization for animal diseases including highly pathogenic avian influenza, foot-and-mouth disease, highly pathogenic blue-ear disease and swine fever. This makes the veterinary vaccine market expand. On the other hand, foreign enterprises, like BI, steps into China by setting up manufacture bases. The development of sino-foreign joint venture enterprises brings more competition and challenge for manufacturing and quality control. Under the situation, it is important to learn the industry development, adjust company strategies, cooperate with industry leaders and collaborate with foreign companies. Therefore, with the support of China Animal Husbandry Group,Yangzhou University, Changchun Veterinary Research Institute from Academy of Military Medical Science, this vaccine summit will be a great communication platform.
Topics include：
Keynote Speech: Veterinary Vaccine Market Trends
Speaker: Mr. Qiyi HU, Vice President, China Animal Husbandry Group
Keynote Speech: Infection Trend and Vaccine Control Strategy of Swine Fever
Speaker: Mr. Huaji QIU, Researcher, Harbin Veterinary Research Institute, CAAS
Keynote Speech: Bird Flu Virus and Vaccine Improvement
Speaker:Yangzhou University
Contacts:
CBI BIZ
Tel: +86 21 5155 1610
Fax: +86 21 5155 2421
Human Vaccine:
Sally Shen, sallyshen@cbichina.com
Veterinary Vaccine:
Abby Zeng, abbyzeng@cbichina.com
Website: http://vaccine.cbibiz.com/51211/index.html